Moderna (MRNA)

Cost of Revenue

$93.00M

Quarterly · Period ending: · USD

MRNA logo

MRNA Cost of Revenue

Latest reported$93.00M
MRNA Quarterly Cost of Revenue ($99.51M → $93.00M)
High-resolution chart · PNG

MRNA cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
93,000,000
955,000,000
452,000,000
1,008,000,000
119,000,000
90,000,000
739,000,000
514,000,000
115,000,000
96,000,000
929,000,000
2,241,000,000
731,000,000
792,000,000
1,918,000,000
1,100,000,000
1,381,000,000
1,017,000,000
952,000,000
722,000,000
750,000,000
193,000,000
15,639,000
8,500,000
7,600,000
7,449,000
8,939,000
7,300,000
7,500,000
7,316,000
7,350,000
6,481,000
104,479,000
90,124,000
5,915,000
5,130,000
99,509,500
99,509,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.